Monitoring and Follow-Up Recommendations Men combining TRT and GLP-1 therapy should establish baseline labs including total and free testosterone, hemoglobin A1C, fasting glucose, lipid panel, liver function, and renal markers
Many studies do not fully control for dietary intake, physical activity, or concurrent lifestyle changes all of which independently affect weight and cardiometabolic risk
Glow notes Each of these products brings its own version of radiance
Experts would eventually find the solution to make synthetic GLP-1 last longer in the body, and GLP-1 medication production took off with the FDA approval of Victoza (2010), Ozempic (2017), and Wegovy (2021)
5,21,22 Although causality is often difficult to establish, clinical case reports and postmarketing pharmacovigilance studies suggest a classwide signal that warrants continued monitoring
Outcomes depend on adherence, dosing, and lifestyle factors